CClinicalTrials.gg
TerminatedNCT04041830LFPQ-FUpdated Aug 7, 2026

Validation of a French-version of the Leeds Food Preference Questionnaire in Normal Weight and Patients With Obesity

An interventional study of Visit 1 and Visit 2 in Normal Weight Adults and Adults With Obesity, sponsored by University Hospital, Clermont-Ferrand. Terminated at 1 site in France. Open to participants aged 20 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Treatment

Why this study was terminated
The sanitary conditions and material restrictions imposed by the CHU and by the university laboratories drastically hampered the realization of this work (with restricted access to the laboratory/department).
Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
20 Years to 55 Years
Sex
All
01

Study summary

While Food reward is an important component of the appetite control to consider, there is actually no tool that has been developed in French to perform its evaluation.

The Leeds Food Preference Questionnaire (LFPQ) is a validated and recognized tool to assess food reward, being however developed for British populations.

The aim of this work is to validate a French version of the LFPQ among lean and obese adults.

Read the detailed description

50 lean and 50 patients with obesity between 20 and 55 years old (50% women and 50% men), will be recruited. After an evaluation of their body composition by impedance meter, and of their dietary status by questionnaires (TFEQ/DEBQ), they will be asked to perform twice the same experimental sessions. They will be asked during this session to arrive at 08:00 am after a 12-hour fast and will receive a calibrated breakfast. Before and after a lunch calibrated meal, they will be asked to perform the French version of the computerized questionnaire LFPQ. Appetite feelings will be assessed at regular intervals.

02

Conditions studied

  • Normal Weight Adults
  • Adults With Obesity

Keywords

  • Appetite
  • Food Reward
  • Methodological approach
03

In context

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • BMI between 30 and 38 kg.m² for the obese patients and 20 and 25 for the lean ones.
  • registered to the national social security system
  • Signed consent

Exclusion criteria

Exclusion Criteria:

  • eating disorders
  • metabolic disease such as hypertension and Type 2 diabetes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
37 participants (actual)

Study arms

  • Experimental
    NW (Normal Weight)

    20 to 55 years old lean adults

    Behavioral: Visit 1 · Behavioral: Visit 2

  • Experimental
    OBESE

    20 to 55 years old adults with obesity

    Behavioral: Visit 1 · Behavioral: Visit 2

Interventions

  • BehavioralVisit 1

    the participants will fill in the LFPQ questionnaire before and after a lunch test meal

  • BehavioralVisit 2

    this is a replication of Visit 1, testing the reproducibility of the LFPQ and of its response to a meal.

06

What researchers measure

Primary outcomes

  1. Change in Food reward

    The participants will be asked to complete the developed French version of the computer-based procedure to measure food reward (Leeds Food Preference Questionnaire; LFPQ) (Finlayson, King et al. 2008).

    Time frame: day 1 , day 8

Secondary outcomes

  1. Body fat mass

    the percentage of body fat and the quantity of fat mass will be assessed using Bio-impedance (BIA)

    Time frame: day 0

  2. Body fat and fat free mass

    the percentage of body fat free and the quantity of fat free mass will be assessed using Bio-impedance (BIA)

    Time frame: day 0

  3. Dietary status

    the level of dietary restriction/disinhibition will be assessed using the TFEQ questionnaire.

    Time frame: day 0

  4. Dietary status

    the level of dietary restriction/disinhibition will be assessed using the DEBQ questionnaire.

    Time frame: day 0

  5. Hunger

    the hunger sensation will be assessed using visual analogue scales of 150 mm.

    Time frame: day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes

  6. Satiety

    the Satiety sensation will be assessed using visual analogue scales of 150 mm.

    Time frame: dday 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes

  7. desire to eat

    the desire to eat sensation will be assessed using visual analogue scales of 150 mm.

    Time frame: day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes

  8. Prospective Food consumption

    the Prospective Food consumption sensation will be assessed using visual analogue scales of 150 mm.

    Time frame: day 1, day 1 + 30minutes, day 1+60minutes, day 1+ 90minutes , day 8, day 8 + 30minutes, day 8+60minutes, day 8+ 90minutes

07

Study locations

1 site
  • Chu Clermont Ferrand
    Clermont-Ferrand, 63003, France
08

References and documents

Publications

  • Thivel D, Oustric P, Beaulieu K, Moore H, Bonjean L, Loglisci J, Georges M, Miyashita M, Boirie Y, Pereira B, Finlayson G. Development, sensitivity and reliability of a French version of the Leeds food preference questionnaire (LFPQ-fr) for the evaluation of food preferences and reward. Physiol Behav. 2023 Aug 1;267:114187. doi: 10.1016/j.physbeh.2023.114187. Epub 2023 Apr 18. PubMed 37080481 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04041830
Lead sponsor
University Hospital, Clermont-Ferrand
Collaborators
Appetite Control and Energy Balance Research Group, UNiversity of Leeds, Leeds, UK, Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
Responsible party
Sponsor
First posted
Aug 1, 2019
Start date
Dec 8, 2019
Primary completion
Jun 25, 2021
Completion
Jun 25, 2021
Last update
Aug 7, 2026

Study contacts

Elodie Gentes
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion